StemCell Therapy

Market Overview:

The anterior uveitis treatment market will show rapid growth due to the increasing cases of the uveitis and the development of novel drugs and treatments. There has been an increasing prevalence of uveitis as it is responsible for an estimated 30,000 new cases of legal blindness annually in the United States and accounts for about 10-15% of all cases of total blindness in the country. Uveitis is a sight-threatening inflammatory disease affecting the uveal layer of the eye. Redness of eyes, blurring of the vision, the small size of the pupil, and sensitivity to light can be possible symptoms of anterior uveitis, which, if not treated, can result in permanent blindness. Thus, there are new developments in the applications of products and treatment modalities that are ongoing. New treatment options for uveitis such as corticosteroids and anti-inflammatory drugs are already gaining traction in the market. In addition, other factors such as the growing geriatric population, rising incidence of the disease, and new product developments are also expected to be some of the driving factors in the growth of the market.

Top Companies in the Anterior Uveitis Treatment Market: AbbVie Inc., Aldeyra Therapeutics, Inc., Alimera Sciences Inc.,, Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Novartis AG, Regeneron Pharmaceuticals, Bausch & Lomb Incorporated and others.

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/01091744599/anterior-uveitis-treatment-market-growth-trends-and-forecast-2020-2025/inquiry?source=Bulletinthenews&Mode=PK67

The report also provides a regional analysis of the Anterior Uveitis Treatment market, including the following regions: North America (the US & Canada), Europe, Asia pacific (China, India and Rest of Asia Pacific), Latin America (Brazil & Rest of Latin America) and Middle East and Africa.

Scope of the Report

As per the scope of the report, anterior uveitis is an eye inflammation that involves the middle layer of the eye. Anterior uveitis is the most common form of uveitis and is the most frequent extra-articular manifestation of ankylosing spondylitis (AS) patients. Untreated anterior uveitis results in loss of vision and permanent eye damage that arises with the development of infections such as glaucoma, retinal edema or cataract. Anterior uveitis can be treated with eye drops containing anti-inflammatory drugs. Corticosteroids have also shown significant results to cure the condition and to treat anterior uveitis. Exploring new drugs and expanding therapeutic applications of existing drugs to include and effectively treat uveitis offers significant growth opportunities for companies involved in the uveitis market.

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/01091744599/anterior-uveitis-treatment-market-growth-trends-and-forecast-2020-2025?source=Bulletinthenews&Mode=PK67

Key Market Trends:

Corticosteroids Segment is Expected to Dominate the Treatment Type Segment During the Forecast Period

Corticosteroids are found dominating the anterior uveitis treatment market as they are first-line therapies for anterior uveitis and are used in the form of eye drops. Corticosteroids are the most preferred option over biologics however researchers are currently exploring biological therapies for the treatment of anterior uveitis.

Corticosteroids are also used in sustained release treatment, i.e., in ocular implants. It has thus shown significant results to cure the condition and researchers are also exploring biological therapies to treat anterior uveitis. In addition, corticosteroids and anti-inflammatory drugs are found gaining traction in the market.

North America is Anticipated to Dominate the Anterior Uveitis Treatment Market

North America is found dominating the market owing to the rising prevalence of the uveitis disease in the United States. There is also an increasing number of key players in the region that is leading to the high growth of this regional segment. The other factors resulting in the growth of the market is the growing geriatric population, and increasing investments in research and development by drug manufacturing companies for innovating new treatments such as corticosteroids.

The market in Asia is also expanding fast for the same reasons the markets in North America and Europe are expanding.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team ([emailprotected])

About Us:

MarketInsightsReportsprovides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process.MarketInsightsReportsprovides and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected] | [emailprotected]

Here is the original post:
Anterior Uveitis Treatment Market Global Research and Clinical Survey Report 2020 to 2025 Novartis AG, Regeneron Pharmaceuticals - BulletintheNews

This entry was posted on January 10, 2020 at 8:42 am and is filed under Blindness. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |